| Literature DB >> 28409277 |
E H H Mommers1,2, B J M Leenders3, W K G Leclercq3, T S de Vries Reilingh4, J A Charbon3.
Abstract
PURPOSE: To evaluate the short- and long-term results after a modified Chevrel technique for midline incisional hernia repair, regarding surgical technique, hospital stay, wound complications, recurrence rate, and postoperative quality of life. These results will be compared to the literature derived reference values regarding the original and modified Chevrel techniques.Entities:
Keywords: Anterior fascia turnover technique; Complications; Modified Chevrel technique; Recurrence; Ventral hernia repair
Mesh:
Year: 2017 PMID: 28409277 PMCID: PMC5517587 DOI: 10.1007/s10029-017-1602-2
Source DB: PubMed Journal: Hernia ISSN: 1248-9204 Impact factor: 4.739
Fig. 1Schematic approach of the modified Chevrel technique. Schematic approach of a modified Chevrel technique for midline ventral hernia repair. From top to bottom the following steps are depicted: anatomical situation with the hernia sac in situ; incision of the anterior rectus fascia and ‘turnover’; suture of both turned over anterior fascias in the midline to form the new posterior layer; fixation of the mesh with continues and single sutures to the lateral remnant of the anterior rectus fascia with 1.5 cm overlap
Demographic characteristics
|
| |
|---|---|
| Gender (male/female) | 84/71 |
| Smoking ( | 26 |
| BMI kg/m2 (median, range) | 28 (18–53 kg/m2) |
| COPD ( | 17 |
| Diabetes Type 2 ( | 20 |
| Previous wound infection ( | 26 |
| Wound healing impairing medication ( | 3 |
| Abdominal aortic aneurism ( | 30 |
| Defect width (median cm, range) | 10 cm (2–25 cm) |
| W1 < 4 cm ( | 7 |
| W2 ≤ 4–10 cm ( | 51 |
| W3 ≥ 10 cm ( | 80 |
| Defect length (median cm, range) | 15 cm (3–35 cm) |
| Defect surface (median cm2, range) | 118 cm2 (5–550 cm2) |
| Type of mesh placed | |
| Standard polypropylene ( | 102 |
| Small pore polypropylene (Marlex) ( | 35 |
| Large pore polypropylene (Vypro I) ( | 18 |
aWound infection after previous surgery
bUse of corticosteroids, chemotherapeutics, or immunosuppressive agents
cPrevious repair of an abdominal aortic aneurism
dExact width measures missing in 17 of 155 patients
Fig. 2Schematic view of the anterior abdominal wall after mesh placement. Ventral ‘birds-eye-view’ after the mesh is fixated to the lateral remnant of the anterior rectus fascia. There is a 1.5 cm overlap between the mesh and the anterior rectus fascia. A continuous suture is used to fixate the mesh to the lateral remnant of the anterior rectus fascia. Single sutures are used to assure that the overlap remains flat on the anterior rectus fascia to facilitate tissue ingrowths in the mesh. The new posterior layer can been seen through the mesh
Concomitant procedures
| Procedure | ( |
|---|---|
| Cholecystectomy | 3 |
| Gastric banding | 1 |
| Parastomal hernia repaira | 2 |
| Hemicolectomy | 1 |
| Enterostomy removal | 2 |
| Enterocutaneous fistula removal | 1 |
| Oophorectomy | 1 |
| Removal of ovarian cyst | 1 |
| Sterilization | 1 |
| Stoppa procedure for bilateral groin hernia | 2 |
Fourteen patients received a total of 15 concomitant procedures with a modified Chevrel repair in the same session
aSugarbaker technique (n = 1, colostomy), suturing hernia defect (n = 1, urostomy)
Complications ≤ 30 days postoperative
| VHWG grade | Patients | CDC I–II (%) | CDC III–IV (%) | Surgical site occurrence (%)c | Surgical site infection (%) | Seroma (%) | Ileus/pneumonia/UTI (%) | |
|---|---|---|---|---|---|---|---|---|
| All patients | Total cohort ( | 30 (17.4) | 9 (5.8) | 31 (19.4) | 9 (5.8) | 16 (10.3) | 8 (5.2) | |
| Grade I | All patients ( | 8 (9.5) | 2 (3.2) | 6 (9.5) | 1 (1.6) | 3 (4.8) | 4 (6.3) | |
| Width < 10 cm ( | 1 (3.8) | 0 | 1 (3.8) | 0 | 1 (3.8) | 0 | ||
| Width ≥ 10 cm ( | 6 (14.3) | 1 (3.6) | 4 (14.3) | 0 | 2 (7.1)a | 3 (10.7) | ||
| Width unknown ( | 1 (11.1) | 1 (11.1) | 1 (11.1)a | 1 (11.1)a | 0 | 1 (11.1) | ||
| Grade II | All patients ( | 20 (22.6) | 6 (7.1) | 22 (26.2) | 7 (8.3) | 12 (14.3) | 4 (4.8) | |
| Width < 10 cm ( | 5 (17.9) | 1 (3.6) | 6 (21.4) | 1 (3.6) | 5 (17.9)a | 0 | ||
| Width ≥ 10 cm ( | 15 (28.6) | 3 (6.1) | 14 (28.6)a | 4 (8.2)a | 7 (14.3)a | 4 (8.2) | ||
| Width unknown ( | 0 | 2 (28.6) | 2 (28.6)a | 2 (28.6)a | 0 | 0 | ||
| Grade III | All patients ( | 2 (25) | 1 (12.5) | 3 (37.5) | 1 (12.5) | 1 (12.5) | 0 | |
| Width < 10 cm ( | 2 (40) | 0 | 2 (40) | 1 (20) | 1 (20.0) | 0 | ||
| Width ≥ 10 cm ( | 0 | 1 (33.3) | 1 (33.3)* | 0 | 0 | 0 | ||
% = percentage of population affected with complication (NB: CDC I–II and CDC III–IV complications may be observed more than once in one patient, hence the percentage of population affected is lower than the times the complication is observed divided by the group size)
UTI Urinary Tract Infection, CDC Clavien-Dindo Classification, VHWG Modified Ventral Hernia Working Group septic risk scale for surgical site occurrences
aOne or more patients within this category required surgical intervention
bExact defect measurements were not available in 16 patients
cStatistically significant difference between VHWG grades
Surgical site occurrence = infection, wound dehiscence, seroma, or development of an enterocutaneous fistula; surgical site infection = deep or superficial wound infection, abscess, infected seroma
Fig. 3Flowchart of study identification and inclusion
Current literature describing the original and modified Chevrel technique
| Population | Defect size | Hospital stay | Wound complications (%) | Follow-up | Recurrences (%) | |
|---|---|---|---|---|---|---|
| Original Chevrel technique | ||||||
| Chevrel [ | 50 | 1–20 cm | NR | 18 (36) | 10 months–114 months | 4 (8) |
| San Pio [ | 67 | NRa | NR | 6 (9) | 5.7 years (range 0–17) | 10 (15) |
| Licheri [ | 64 | 5–15 cm | 10 days (2–21) | 17 (26.5) | 54 months | 2 (3.5) |
| Forte [ | 9 | 5–10 cm | 9 days (5–18) | 4 (44) | NR | 3 (33) |
| Marchesi [ | 21 | ±8 cm | 11 days (4–58) | 7 (33) | 17 months | 0 (0) |
| Hodgman [ | 123 | 65 cm2 | 5 days (0–31) | 40 (34) | 18 months | 6 (5) |
| Modified Chevrel technique’s | ||||||
| Chevrel [ | 12 | >10 cm | NR | 3 (25) | 30 months–8 years | 0 (0) |
| Whiteley [ | 10 | NRa | NR | 0 (0) | 17 months | 0 (0) |
| Khaira [ | 35 | NRa | 6 days (1–27) | 8 (22) | 20 months, (range 6–54) | 0 (0) |
| Joshi [ | 30 | >4 cm | 5 days SD ± 4 | 3 (10) | 12 months | 0 (0) |
| Mommers [ | 155 | 10 cm | 5 days (2–95) | 27 (19) | 52 months (median) | 2 (2)* |
Characteristics of all included studies; Wound complications = wound/mesh infection, seroma, haematoma, or wound dehiscence
NR not reported in the publication
aOnly patients with a follow-up ≥12 months were included (n = 110), values can be average, median or range, depending on the original publication